Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: percocet / quinine attending: chief complaint: increasing fatigue major surgical or invasive procedure: mitral valve repair with 26 millimeter band history of present illness: this is a 49 yo african - american male with severe mr htn for past 10 years. this has progressed significantly and the patient has had increasing fatigue. he was referred for mvrepair vs. replacement and was admitted pre-operatively to the csru for swan placement. he had dialysis this morning prior to admission. he has esrd and is on dialysis for the past 2 years. he is also anticipating renal transplant in the near future and his wife is the planned donor. catheterization prior to this admission showed elevated ra pressures (17) with pa 92/38, and wedge 40, ci 1.7, ef 42% with effective ef 29%. he also had global hk, mod. mr, mod. tr, mild pr. past medical history: severe mr . htn chf htn iddm mild gerd esrd ( on hd 2 years) s/p r index finger amp. ? eye surgery social history: mmarried. no etoh/tobacco/drugs family history: no premature cad physical exam: general - nad heent - perrl, eomi, sclera non-iceric neuro - cn ii-xii grossly intact, mae strengths lungs - cta bilaterally heart - rrr with 2/6 diastolic murmur abd - soft, nt, nd, + bs ext - no peripheral edema, dp 2+ nilat. with warm extrems pertinent results: 08:00am blood wbc-9.4 rbc-3.48* hgb-11.2* hct-33.1* mcv-95 mch-32.2* mchc-33.8 rdw-15.1 plt ct-365 03:32pm blood wbc-11.0 rbc-3.73* hgb-12.9* hct-37.3* mcv-100* mch-34.6* mchc-34.6 rdw-14.5 plt ct-177 08:00am blood pt-14.3* ptt-29.9 inr(pt)-1.4 08:00am blood plt ct-365 08:00am blood glucose-143* urean-51* creat-9.3*# na-134 k-5.2* cl-92* hco3-25 angap-22* 03:32pm blood alt-22 ast-26 alkphos-141* totbili-0.7 03:32pm blood glucose-47* urean-25* creat-6.5* na-141 k-4.5 cl-94* hco3-36* angap-16 08:00am blood calcium-9.7 phos-7.5*# mg-2.7* 06:27pm blood freeca-1.09* brief hospital course: just prior to admission, patient underwent hemodialysis. he was then directly admitted to floor, then to the csru for swan placement and evaluation of pressures and volume status. he was subsequently started on a nitro drip for pulmonary hypertension. he remained hemodynamically stable. the following day, he underwent a mv repair with dr. , and was transferred to csru in stable condition on epinephrine, milrinone, insulin, and propofol drips. he awoke neurologically intact and was extubated on pod#2. he continued on his regular dialysis schedule. his inotropic support was gradually weaned over several days. an echocardiogram on pod#4 revealed only trivial mr and a lvef of 55% - improved from prior studies. he otherwise maintained stable hemodynamics and remained in a normal sinus rhythm. medical therapy was optimized and he was transferred to the floor on pod#7. he was followed closely by the renal and cardiology services. he worked daily with physical therapy. he continued to make clinical improvements and was cleared for discharge to home on pod#8. at time of discharge, he was tolerating room air and his chest x-ray showed improved aeration and chf with only a small residual left pleural effusion. he had adequate pain control with dilaudid. medications on admission: digoxin 0.125 mg daily glipizide 10 mg daily insulin nph 10 units avandia 4 mg daily lopressor 75 mg norvasc trandolapril 4 mg daily zantac 150 mg daily nephrocap one cap daily discharge medications: 1. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 3. hydromorphone 2 mg tablet sig: one (1) tablet po every four (4) hours as needed. disp:*40 tablet(s)* refills:*0* 4. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 5. ranitidine hcl 150 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 6. isosorbide mononitrate 60 mg tablet sustained release 24hr sig: one (1) tablet sustained release 24hr po daily (daily). disp:*30 tablet sustained release 24hr(s)* refills:*2* 7. nephrocaps 1 mg capsule sig: one (1) capsule po once a day. disp:*30 capsule(s)* refills:*2* 8. zestril 40 mg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*0* 9. phoslo 667 mg tablet sig: two (2) tablet po qac. disp:*60 tablet(s)* refills:*0* 10. glucotrol xl 10 mg tab, sust release osmotic push sig: one (1) tab, sust release osmotic push po once a day. 11. avandia 4 mg tablet sig: one (1) tablet po once a day. discharge disposition: home with service facility: homecare discharge diagnosis: s/p mv repair end stage renal disease/ hemodialysis insulin dependent diabetes mellitus . hypertension congestive heart failure hypertension gastro-esoph. reflux disease right upper extrem av fistula discharge condition: good discharge instructions: no lotions, powders or creams on incision may shower, and pat wound dry no lifting greater than 10 pounds for 10 weeks no driving for one month followup instructions: see dr. in weeks see dr. in office at 4 weeks dr. 2 weeks procedure: extracorporeal circulation auxiliary to open heart surgery hemodialysis annuloplasty transfusion of packed cells injection or infusion of nesiritide diagnoses: end stage renal disease esophageal reflux mitral valve disorders congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled diseases of tricuspid valve 

Answer: The patient is high likely exposed to